[Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic].

Z Evid Fortbild Qual Gesundhwes

Universität zu Köln, Medizinische Fakultät und Uniklinik Köln, Klinik I für Innere Medizin, Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf, Köln, Deutschland; Deutsches Zentrum für Infektionsforschung (DZIF), Partnerstandort Bonn-Köln, Köln, Deutschland; Klinik für Innere

Published: February 2023


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: This study describes the development and validation of structure indicators for clinical infectious disease (ID) care in German hospitals, which is important to adequately face the future challenges in ID medicine.

Methods: A team of experts developed the structure indicators in a three-stage, multicriteria decision-making process: (1) identification of potential structure indicators based on a literature review, (2) written assessment process, and (3) face-to-face discussion to reach consensus and final selection of appropriate structure indicators. A field study was conducted to assess the developed structure indicators. A score based on the structure indicators was determined for each hospital and validated via receiver operator characteristic (ROC) curves using externally validated ID expertise (German Society of ID (DGI) Centre).

Results: Based on a list of 45 potential structure indicators, 18 suitable indicators were developed for clinical ID care structures in German hospitals. Out of these, ten key indicators were defined for the general and coronavirus disease 2019- (COVID-19-) specific clinical ID care structures. In the field survey of clinical ID care provision for COVID-19 patients in 40 German hospitals, the participating facilities achieved 0 to 9 points (median 4) in the determined score. The area under the ROC curve was 0.893 (95% CI: 0.797, 0.988; p < 0.001).

Discussion/conclusion: The structure indicators developed within the framework of a transparent and established development process can be used in the future to both capture the current state and future developments of ID care quality in Germany and enable comparisons.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901538PMC
http://dx.doi.org/10.1016/j.zefq.2022.11.005DOI Listing

Publication Analysis

Top Keywords

structure indicators
32
german hospitals
16
potential structure
12
clinical care
12
indicators
10
structure
8
indicators clinical
8
clinical infectious
8
infectious disease
8
disease care
8

Similar Publications

Cadmium (Cd) contamination in coastal regions poses severe environmental risks, yet bacterial defense mechanisms against Cd remain poorly understood. This study unveils distinct tolerant strategies of two highly Cd-tolerant bacteria isolated from the Yangtze River estuary: Comamonas sp. Y49 and Aeromonas sp.

View Article and Find Full Text PDF

In-silico modeling of SHLP6: A novel mitochondrial peptide controlling neurodegeneration and cellular aging.

Comput Biol Med

September 2025

Institute of Biotechnology, Department of Medical Biotechnology, SIMATS Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, 602105, Tamil Nadu, India. Electronic address:

Small humanin-like peptide-6 (SHLP6), is derived from the mitochondrial genome. The 3D structure of SHLP6 was evaluated using PEPstr, with homology modeling predicting a Cyt-C structure with a DOPE score of -645.717 and a GA341 score of 0.

View Article and Find Full Text PDF

Maladaptive role of peridroplet mitochondria during lipophagy disruption in pancreatic cancer.

Biochem Biophys Res Commun

September 2025

Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-city, Chiba, 260-8675, Japan. Electronic address:

Pancreatic ductal adenocarcinoma (PDAC) cells exhibit high metabolic flexibility, enabling survival under glucose limitation by using alternative fuels such as fatty acids. Lipophagy, a selective form of autophagy targeting lipid droplets (LDs), supports mitochondrial respiration during such nutrient stress. Our previous study demonstrated that the LSD1 inhibitor SP-2509 disrupts lipophagy independently of LSD1 inhibition, leading to LD accumulation and ATP depletion in glycolysis-suppressed PDAC cells.

View Article and Find Full Text PDF

Mapping between chain configuration and mechanical properties of poly(L-lactic acid) monofilaments via hydrolysis induction.

J Mech Behav Biomed Mater

August 2025

School of Mechanical Engineering, Jiangsu Key Laboratory for Design and Manufacturing of Precision Medicine Equipment, Southeast University, Nanjing, 211189, China. Electronic address:

Poly(L-lactic acid) (PLLA), as a substrate material, has been widely utilized in the field of biodegradable vascular stents. Prior to implantation, it is particularly crucial for these devices to assess the relationship of the mechanical properties and microstructures during full degradation cycle. Although previous studies have primarily focused on structural parameters such as crystallinity and molecular weight, there are relatively few reports that explore the impact of microstructure on mechanical performance from the perspective of chain configuration during the degradation.

View Article and Find Full Text PDF

Wastewater as a dual indicator of human and environmental exposure to synthetic antioxidants: Occurrence and fate in biological and advanced wastewater treatment.

Environ Int

August 2025

Eawag: Swiss Federal Institute of Aquatic Science and Technology, Ueberlandstrasse 133, 8600, Duebendorf, Switzerland; Institute of Biogeochemistry and Pollutant Dynamics, Universitaetstrasse 16, 8092, Zurich, Switzerland. Electronic address:

Synthetic antioxidants (SAOs) are widely used additives in industrial and consumer products, yet their human exposure and fate throughout wastewater treatment remain poorly understood. This study investigates the occurrence of SAOs and their human metabolites in wastewater influent as well as their abatement in three wastewater treatment plants (WWTPs) employing both conventional and advanced treatment technologies. In vitro human liver S9 assays were performed to generate a SAO metabolite MS2 library containing over 2500 potential metabolites, which was matched against wastewater influent data.

View Article and Find Full Text PDF